Related Experiment Videos
[Pregnancy in hyperprolactinemic patients]
M Ventz1, B Puhlmann, G Knappe
1IV. Med. Klinik und Poliklinik, Humboldt-Universität (Charité), Berlin.
Zentralblatt Fur Gynakologie
|January 1, 1996
Summary
Hyperprolactinemia in pregnancy, often treated with dopaminergic drugs, typically results in successful deliveries. Postpartum prolactin levels vary based on tumor size, with no major complications observed during pregnancy.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Neurosurgery
Context:
- Hyperprolactinemia, a condition characterized by elevated prolactin levels, affects fertility and pregnancy outcomes.
- Pituitary adenomas, specifically microadenomas and macroadenomas, are common causes of hyperprolactinemia.
- Management of hyperprolactinemia during pregnancy involves careful consideration of treatment options and potential tumor behavior.
Purpose:
- To analyze the outcomes of pregnancies in hyperprolactinemic patients.
- To evaluate the impact of different treatments (dopaminergic agents, surgery) on pregnancy and postpartum prolactin levels.
- To assess tumor behavior and complications during pregnancy in this cohort.
Summary:
- This retrospective study analyzed 27 pregnancies in 17 hyperprolactinemic patients, with pituitary adenomas identified in most.
- Pregnancy was primarily achieved through dopaminergic treatment, with discontinuation upon recognition; surgical outcomes for microadenomas and macroadenomas varied in achieving normal prolactin levels.
- Most pregnancies resulted in live births (19 spontaneous, 3 Cesarean sections), with 3 induced terminations and 1 miscarriage; postpartum prolactin levels showed distinct patterns for micro- and macroadenomas.
- Tumor size changes were minimal and clinically insignificant post-delivery; no pregnancy complications arose from the tumors in treated patients, though breastfeeding success was around 50%.
Impact:
- Provides insights into the reproductive health of women with hyperprolactinemia and pituitary adenomas.
- Informs clinical management strategies for hyperprolactinemia during pregnancy, including treatment choices and monitoring.
- Highlights the generally safe course of pregnancy in treated hyperprolactinemic patients, despite varying prolactin level dynamics and breastfeeding challenges.